TrialSite News

Early Stage

Media and analysis to medical research

Analytics

Raised to Date: Raised: $57,200

Aggregate Commitments $

Platform

PicMii

Start Date

06/08/2022

Close Date

12/01/2022

Min. Goal

$50,001

Max. Goal

$249,999

Min. Investment

$1,000

Security Type

Equity - Common

Funding Type

RegCF

Series

Pre-Seed

Price Per Share

$2.10

Pre-Money Valuation

$11,600,637

Rolling Commitments $

Status

Active

Reporting Date

06/25/2022

Days Remaining

159

% of Min. Goal

114%

% of Max. Goal

23%

Likelihood of Max
extremely
Avg. Daily Raise

$3,365

Momentum
warm.svg
Create a free account today to gain access to KingsCrowd analytics.
Location

Wilmington, Delaware

Industry

Media, Entertainment & Publishing

Tech Sector

MediaTech

Distribution Model

B2C

Margin

Low

Capital Intensity

Low

Business Type

High Growth

TrialSite News, with a valuation of $11.8 million, is raising funds on PicMii. The company provides unbiased, objective, and independent media and analysis to medical research. The business publishes complex medical research for its subscribers, including physicians, healthcare professionals, patients, and investors. TrialSite News is a social and media network dedicated to medical research. The business is expected to reach 10,000 subscribers and $500,000 to $1 million in revenue by the end of 2022. Daniel O’Conner founded TrialSite News in April 2021. The current crowdfunding campaign has a minimum target of $50,001 and a maximum target of $249,998.70. The campaign proceeds will be used to add more subscribers and generate more revenues.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$256,345

$0

COGS

$0

$0

Tax

$9,751

$0

 

 

Net Income

$72,188

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$116,777

$0

Accounts Receivable

$0

$0

Total Assets

$133,101

$0

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 06/08/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
TrialSite News on PicMii 2022
$
Platform: PicMii
Security Type: Equity - Common
Valuation: $11,600,637

Follow company

Follow TrialSite News on PicMii 2022
View on PicMii
Bullish / Bearish
You're Bullish on TrialSite News on PicMii 2022

Thank you for your vote on TrialSite News on PicMii 2022

Bullish / Bearish
You're Bearish on TrialSite News on PicMii 2022

Thank you for your vote on TrialSite News on PicMii 2022